SCHEMBL5586077

SCHEMBL5586077

CCOC1(OCC)CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9712164 0.93
SCHEMBL9712178 0.91
SCHEMBL6762569 0.90
SCHEMBL5585792 0.84
SCHEMBL6685764 0.83 OPRM1 (0.30)
SCHEMBL6684870 0.79 LTA4H (0.33)
SCHEMBL5585758 0.77
SCHEMBL5585337 0.76
SCHEMBL5585657 0.76
SCHEMBL5585716 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836238-A1 FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM Bridgestone Corporation (JP) 2007-09-26 EP claimed
WO-2006076629-A1 FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM BRIDGESTONE CORPORATION (JP) 2006-07-20 WO claimed
EP-0816359-B1 4-Amino-2-ureido-pyrimidine-5-carboxamides, processes for their preparation, medicaments containing these compounds, and their use AVENTIS PHARMA GMBH (DE) 2004-11-03 EP claimed
US-5773447-A 4-AMINO-2-UREIDOPYRIMIDINE-5-CARBOXAMIDE FORMED BY AMIDATION HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-30 US claimed
EP-0816359-A1 4-Amino-2-ureido-pyrimidine-5-carboxamides, processes for their preparation, medicaments containing these compounds, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-07 EP claimed
EP-4608452-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS Eisai R&D Management Co., Ltd. (JP) 2025-09-03 EP disclosed
EP-4551580-A2 CRYSTALLINE MONOMERS FOR PREPARING ANTISENSE OLIGONUCLEOTIDES AND METHODS OF THEIR PREPARATION AND USE Eisai R&D Management Co., Ltd. (JP) 2025-05-14 EP disclosed
WO-2025095980-A1 ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-05-08 WO disclosed
EP-4291552-B1 MODULATORS OF COMPLEX I BOEHRINGER INGELHEIM INT (DE) 2025-04-09 EP disclosed
US-20250092392-A1 ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-03-20 US disclosed
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 WO disclosed
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 WO disclosed
WO-2000012563-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE ISIS PHARMACEUTICALS, INC. (US) 2000-03-09 WO disclosed
US-5773447-A 4-AMINO-2-UREIDOPYRIMIDINE-5-CARBOXAMIDE FORMED BY AMIDATION HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-30 US disclosed
EP-0816359-A1 4-Amino-2-ureido-pyrimidine-5-carboxamides, processes for their preparation, medicaments containing these compounds, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-07 EP disclosed
US-4282201-A Pharmaceutical comprising drug and polymer ALZA CORPORATION (US) 1981-08-04 US disclosed
US-4279918-A ANTIDEPRESSANTS, STIMULANTS BYK GULDEN LOMBERG CHEMISCHE FABRIK G.M.B.H. (DE) 1981-07-21 US disclosed
US-4259102-A Composition comprising useful agent such as fertilizers, housed in heterocyclic polymer ALZA CORPORATION (US) 1981-03-31 US disclosed
US-4246397-A Polymers comprising heterocyclic system ALZA CORPORATION (US) 1981-01-20 US disclosed
US-4211867-A ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS MCNEIL LABORATORIES, INCORPORATED (US) 1980-07-08 US disclosed